26
https://pubmed.ncbi.nlm.nih.gov/38114788
Mirvetuximab soravtansine shows superior efficacy compared to chemotherapy in treating platinum-resistant epithelial ovarian cancer.
https://pubmed.ncbi.nlm.nih.gov/38114788
Mirvetuximab soravtansine shows superior efficacy compared to chemotherapy in treating platinum-resistant epithelial ovarian cancer.